Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

332
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
332

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sports Nephrology: From Bench to Bedside.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm study.

Health technology assessment (Winchester, England)·2026
Same author

American Board of Internal Medicine Nephrology: Pressing Issues and Insights.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Practical Considerations for Infection Prevention with the Clinical Use of Complement Inhibitors.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Impact of Treatment Modalities on Intensive Care Unit Length of Stay for Patients Admitted With Severe Hyponatremia.

The Annals of pharmacotherapy·2025
Same author

Use of the Desmopressin Clamp in Hyponatremia: Smooth Sailing or Turbulent Waters?

Kidney360·2025
Same journal

Variants to Functions to Therapeutic Strategies Toward Genomically Informed Care for Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Personalizing Cardio-Kidney-Metabolic Therapy: Closer But Not There Yet.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Autosomal Dominant Tubulointerstitial Kidney Disease: My Kingdom for a Biomarker.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Beyond the Margin: Improving Noninferiority Trials of Kidney Transplant Immunosuppression.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Parathyroid Hormone Receptor 1 Facilitates Cyst Growth in Genetic Models of Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
Same journal

Alanyl-tRNA Synthetase 1 and Cyst Growth in Autosomal Dominant Polycystic Kidney Disease.

Journal of the American Society of Nephrology : JASN·2026
See all related articles

Related Experiment Video

Updated: May 30, 2025

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

15.9K

Post-transplant Thrombotic Microangiopathy.

Anuja Java1, Matthew A Sparks2,3, David Kavanagh4,5

  • 1Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.

Journal of the American Society of Nephrology : JASN
|January 31, 2025
PubMed
Summary
This summary is machine-generated.

Thrombotic microangiopathy (TMA) after kidney transplant is a serious complication. Understanding complement

Keywords:
clinical immunologycomplementgenetic renal diseaseglomerular diseasehemolytic uremic syndrome

More Related Videos

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
10:31

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model

Published on: August 13, 2017

7.6K
Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models
09:23

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Published on: September 22, 2023

2.6K

Related Experiment Videos

Last Updated: May 30, 2025

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

15.9K
Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
10:31

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model

Published on: August 13, 2017

7.6K
Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models
09:23

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models

Published on: September 22, 2023

2.6K

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Hematology

Background:

  • Thrombotic microangiopathy (TMA) is a severe complication post-kidney transplant, impacting graft and patient survival.
  • TMA presents with hemolytic anemia, thrombocytopenia, and organ damage due to microvascular thrombosis.
  • Causes include genetic/acquired defects (complement-mediated TMA) and other conditions like infections or autoimmune diseases.

Purpose of the Study:

  • To review the pathophysiologic mechanisms of various post-transplant TMAs.
  • To highlight the critical role of complement activation in TMA pathogenesis.
  • To emphasize the importance of genetic testing for complement disorders.

Main Methods:

  • Literature review of pathophysiologic mechanisms in post-transplant TMA.
  • Analysis of clinical features and diagnostic challenges.
  • Discussion of therapeutic implications, including anticomplement therapy.

Main Results:

  • Recurrent TMA is typically complement-mediated; de novo TMA can also involve complement overactivation.
  • Differentiating complement-mediated TMA is crucial for appropriate treatment and prognosis.
  • Genetic testing for complement disorders aids diagnosis and management of recurrent TMA.

Conclusions:

  • Complement activation plays a central role in many forms of post-transplant TMA.
  • Early recognition and timely anticomplement therapy are vital for preventing graft failure.
  • Genetic testing and understanding TMA mechanisms are key for optimal patient outcomes.